JANUS HENDERSON GROUP PLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72,169
-55.3%
33,963
+0.0%
0.00%
Q2 2023$161,454
-16.8%
33,954
+0.0%
0.00%
Q1 2023$194,115
+24.8%
33,938
+120.1%
0.00%
Q4 2022$155,505
-99.5%
15,419
-99.5%
0.00%
-100.0%
Q3 2022$31,960,929
-10.2%
2,849,452
+98.5%
0.02%
-4.0%
Q2 2022$35,572,000
-37.6%
1,435,513
-2.3%
0.02%
-10.7%
Q1 2022$56,970,000
-36.9%
1,469,400
-4.7%
0.03%
-26.3%
Q4 2021$90,259,000
-11.6%
1,542,604
-10.4%
0.04%
-15.6%
Q3 2021$102,052,000
-35.6%
1,721,811
-5.7%
0.04%
-33.8%
Q2 2021$158,477,000
+1.1%
1,825,984
-3.9%
0.07%
-5.6%
Q1 2021$156,707,000
-32.3%
1,900,632
-25.3%
0.07%
-33.3%
Q4 2020$231,467,000
+82.9%
2,545,568
-19.6%
0.11%
+63.6%
Q3 2020$126,574,000
+0.8%
3,166,709
-13.5%
0.07%
-5.7%
Q2 2020$125,556,000
+71.5%
3,659,394
+11.0%
0.07%
+40.0%
Q1 2020$73,196,000
+37055.3%
3,295,619
+32685.7%
0.05%
Q4 2019$197,00010,0520.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$197,709,00022.51%
Redmile Group, LLC 12,957,222$758,127,00017.24%
Grosvenor Holdings, L.L.C. 1,037,256$60,690,0006.28%
Casdin Capital, LLC 3,400,000$198,934,0005.61%
Ally Bridge Group (NY) LLC 270,000$15,798,0005.52%
DAFNA Capital Management LLC 372,160$21,775,0005.48%
Tri Locum Partners LP 142,032$8,310,0003.27%
Kynam Capital Management, LP 95,561$5,591,0002.99%
Artal Group S.A. 1,800,000$105,318,0002.86%
Bellevue Group AG 3,775,736$220,918,0002.28%
View complete list of FATE THERAPEUTICS INC shareholders